Helen of Troy Limited reported unaudited consolidated earnings results for the third quarter and nine months ended November 30, 2013. For the quarter, the company reported net sales revenue of $380.730 million compared to $374.599 million a year ago. Operating income was $49.393 million compared to $47.052 million a year ago. Income before income taxes was $46.893 million compared to $43.804 million a year ago. Net income was $37.524 million or $1.16 per diluted share compared to $37.719 million or $1.18 per diluted share a year ago. Adjusted EBITDA was $60.512 million compared to $57.107 million a year ago.

For nine months, the company reported net sales revenue of $1,004.633 million compared to $962.221 million a year ago. Operating income was $100.374 million compared to $109.041 million a year ago. Income before income taxes was $92.880 million compared to $99.405 million a year ago. Net income was $75.233 million or $2.33 per diluted share compared to $84.159 million or $2.64 per diluted share a year ago. Adjusted EBITDA was $146.911 million compared to $140.032 million a year ago. Adjusted diluted EPS was $2.70. Adjusted operating income (operating income without non-cash asset impairment charges) was $112.4 million compared to $109.0 million for the same period last year, an increase of 3.1%. Adjusted income (net income without non-cash asset impairment charges) was $87.3 million, or $2.70 per fully diluted share, compared to $84.2 million, or $2.64 per fully diluted share, in the first nine months of fiscal year 2013. This represents an increase in adjusted income of 3.7% and in adjusted diluted earnings per share of 2.3%.

For the fourth quarter of 2013, the company expects diluted EPS in the range of $0.80 to $0.90.

For fiscal year 2014, the Company continues to expect net sales revenue in the range of $1.29 billion to $1.32 billion, and diluted EPS in the range of $3.13 to $3.23, which includes the non-cash asset impairment charges of $0.37 per share recorded in the first quarter of fiscal year 2014. The Company expects adjusted diluted EPS to be in the range of $3.50 to $3.60, which is consistent with the Company's previous guidance. The earnings guidance reflects the negative impact of the difficult retail environment, a normal cold/cough/flu season, product cost increases across all segments, an increase in non-cash compensation expense for the Company's CEO, and an incentive compensation program for the Healthcare/Home Environment segment. The Company expects capital expenditures for fiscal year 2014 to be in the range of $40 million to $45 million, with approximately $33 million related to the completion of the Company's new 1.3 million square foot distribution center in Olive Branch, Mississippi. The company expects diluted EPS in the range of $3.13 to $3.23. The company expects adjusted diluted EPS in the range of $3.50 to $3.60.